Lung volume changes with synchronized noninvasive ventilator support in preterm infants
Intrapulmonary Volume Changes During Synchronized Noninvasive Positive Pressure Ventilation In Preterm Infants
This study will use a noninvasive imaging belt to see if synchronized ventilator inflations produce larger lung volumes than unsynchronized or backup inflations in very preterm infants on sNIPPV.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 27 (estimated) |
| Ages | N/A to 4 Weeks |
| Sex | All |
| Sponsor | University of Zurich Academic / other |
| Locations | 1 site (Zurich, Canton of Zurich) |
| Trial ID | NCT07237139 on ClinicalTrials.gov |
What this trial studies
This observational study records lung impedance with Electrical Impedance Tomography (EIT) in preterm infants receiving synchronized noninvasive positive pressure ventilation (sNIPPV). An EIT belt and pulse oximeter are applied and recordings include a 2-minute CPAP baseline followed by return to sNIPPV while the ventilator and abdominal capsule (Graseby) provide synchronization. The primary endpoint is the difference in relative tidal volume (rel. Delta-Z) between spontaneous breaths and synchronized inflations; secondary analyses examine regional aeration and ventilation differences. The ventilator used is the EVEneo and the protocol compares spontaneous, synchronized, non-synchronized, and backup inflations to characterize intrapulmonary mechanisms.
Who should consider this trial
Good fit: Ideal candidates are infants born before 30 0/7 weeks gestation, under 4 weeks old, receiving synchronized NIPPV and whose parents provide written informed consent.
Not a fit: Infants with severe congenital malformations affecting lung aeration or perfusion, those judged too unstable by the treating physician, older than 4 weeks, or not receiving sNIPPV are unlikely to benefit from participation.
Why it matters
Potential benefit: If successful, the results could help clinicians fine-tune ventilator timing to improve lung aeration and possibly reduce respiratory failure in very preterm infants.
How similar studies have performed: Clinical trials have shown synchronized NIPPV reduces respiratory failure compared with non‑synchronized modes, but using EIT to detail the intrapulmonary volume changes during different inflation types is a relatively novel, more mechanistic application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Written informed consent by one or both parents or legal guardians * Gestational age at birth \< 30 0/7 weeks * Infants on sNIPPV respiratory support * Below 4 weeks chronological age Exclusion Criteria: * Severe congenital malformation adversely affecting lung aeration or perfusion (e.g., congenital heart defects) * Too ill/unstable in the opinion of the treating physician.
Where this trial is running
Zurich, Canton of Zurich
- University Hospital Zurich — Zurich, Canton of Zurich, Switzerland (Recruiting)
Study contacts
- Study coordinator: Christoph M Rüegger, MD
- Email: christoph.rueegger@usz.ch
- Phone: +41432539810
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.